Tuesday, September 05, 2017 10:15 AM

NEW RESEARCH FINDS VALUE IN PSA TESTING

By Dennis Thompson

HealthDay Reporter

TUESDAY, Sept. 5, 2017 (HealthDay News) -- Despite ongoing debate over the value of prostate cancer[1] screening, a new review says it can indeed reduce a man's risk of dying from the disease.

Early tumor detection using the prostate[2]-specific antigen[3] (PSA[4]) blood[5] test lowers a man's risk of prostate cancer death by 25 percent to 32 percent, the new analysis of two major trials of PSA testing found.

"The amount of early diagnosis was very strongly correlated with the reduced risk of prostate cancer death," said senior researcher Ruth Etzioni, a biostatistician with the Fred Hutchinson Cancer Research Center in Seattle.

However, there's still a good chance that many men will wind up treated for prostate cancer[6] that would not have ...

News source: WebMD

See also: The Robotic Urologist